Use of macrolides in the 2009 H1N1 virus infection outbreak: a survey of general practices in Japan.
Division of Pulmonary Medicine, Infectious Diseases and Oncology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan. Electronic address: a-azuma@nms.ac.jp.
Arata
A
Azuma
Mutsuo
M
Yamaya
Jun-Ichi
J
Kadota
Keiichi
K
Mikasa
Shoji
S
Kudoh
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000998:Antiviral Agents / Q000008:administration & dosage; D060085:Coinfection / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D004196:Disease Outbreaks; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D007564:Japan / Q000453:epidemiology; D018942:Macrolides / Q000008:administration & dosage*; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D010818:Practice Patterns, Physicians'; D055656:Prescriptions / Q000706:statistics & numerical data*; D012189:Retrospective Studies; D013997:Time Factors
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D018942:Macrolides
Antibiotics; Macrolides; Pandemic influenza virus; Physician